<DOC>
	<DOCNO>NCT00692341</DOCNO>
	<brief_summary>This study evaluate effect mild moderate impairment hepatic function single-dose pharmacokinetics , safety tolerability AG-013736 .</brief_summary>
	<brief_title>Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Axitinib</mesh_term>
	<criteria>Diagnosis reduce hepatic function ( Child Pugh Classification A B ) Body Mass Index 1832 kg/m2 History febrile illness within 5 day prior first dose Any condition possibly affect drug absorption ( e.g . gastrectomy ) Positive urine drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>hepatic impairment</keyword>
</DOC>